Finding MECP2 modifier genes
The existence of girls and women who do not have Rett Syndrome but who do have common MECP2 mutations, has led researchers to believe that there are other genes, yet unidentified, which protect those individuals from the damaged MECP2.
In a project underway at Baylor College of Medicine in Houston, the laboratory of Monica Justice, Ph.D., aims to identify those advantageous gene modifiers and provide new avenues for treatment in girls and women who do have Rett symptoms.
Click here to read a blog interview with Dr Monica Justice.
RSRT UK funding delivered to this project:
September 2011: £16,000